- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04685707
Visual Feedback Monitoring During Exercise in Individuals With Obesity
Exercise has been shown to offer numerous health benefits and be particularly important in preventing weight gain or regain for people with obesity. Exercise guidelines can be difficult to interpret and apply independently and do not address specific exercise limitations in individuals with obesity. The exercise monitoring system proposed in this study might provide a new method to meet aerobic exercise guidelines independently with reduced risk of injury.
The exercise monitoring system controls, in real-time, the intensity of an exercise session consisting of treadmill walking. During treadmill walking, the exercise monitoring system will instruct participants to increase or decrease how much participants raise their knees and swing their arms while maintaining a smooth contact with the ground, based on real-time readings of the participants' heart rate.
In this clinical trial, each participant will perform a control and an experimental training session. Both training sessions will include four blocks of 7 minutes of treadmill walking alternated with three periods of rest (3 min). In the control session, participants will monitor the intensity of exercise independently using a standard heart rate monitor and control it by adjusting their walking speed. In the experimental session, each participant will follow the exercise monitoring system instructions displayed on a TV, and treadmill walking speed will be set at a comfortable walking speed. Target heart rates of 60% HRR will be used as the exercise intensities in both training sessions. The investigators will examine energy expenditure, heart rate, and kinematic measures under control and experimental conditions. The goals of this clinical trial are to determine the effect of exercising with the exercise monitoring system in individuals with obesity. The investigators hypothesized that the experimental session will result in higher total energy cost and efficiency than the control session; and in lower heart rate error, tibial positive peak accelerations and feedback errors than the control session.
The results of this study will inform proposals for larger interventions that will focus on 1) testing different types of obesity and osteoarthritis, 2) adding a resistance-training component, and 3) integrating a diet intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39402
- The University of Southern Mississippi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI ≥ 30.0 kg/m2 and ≤ 40.0 kg/m2
- Age 20 to 45 years;
- Able to understand spoken English at the level needed to:
- understand and follow instructions for equipment setup, testing, and task performance
- answer questions related to effort and preference
- be able to understand consent document and provide informed assent
Exclusion Criteria:
- Any signs or symptoms suggestive of cardiovascular, pulmonary, metabolic, or renal disease.
- Any injury or health condition that affects the ability to walk on a treadmill.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HFFS, then Control
Participants first performed the HFFS (increased hip flexion) exercise session.
After a washout period of at least 24h, they then performed the Control (walking/running) exercise session.
|
Participants will follow the exercise monitoring system's instructions displayed on a TV.
Treadmill walking speed will be set at a comfortable walking speed.
Participants will monitor the intensity of exercise independently using a standard heart rate monitor and control it by adjusting the treadmill speed (walking speed).
|
|
Experimental: Control, then HFFS
Participants first performed the Control (walking/running) exercise session.
After a washout period of at least 24h, they then performed the HFFS (increased hip flexion) exercise session.
|
Participants will follow the exercise monitoring system's instructions displayed on a TV.
Treadmill walking speed will be set at a comfortable walking speed.
Participants will monitor the intensity of exercise independently using a standard heart rate monitor and control it by adjusting the treadmill speed (walking speed).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Energy Expenditure (Oxygen Consumption)
Time Frame: 1 Day
|
Energy expenditure was evaluated from oxygen consumption (ml/kg/min) measured during the exercise and recovery bouts using a breath-by-breath portable metabolic analyzer (K5, COSMED, Rome, Italy).
|
1 Day
|
|
Heart Rate (Bpm)
Time Frame: 1 day
|
Average heart rate (bpm) during steady state period of exercise.
|
1 day
|
|
Percentage of Strides With Tibia Peak Positive Accelerations Above 3g
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Tibial Positive Peak Acceleration
Time Frame: Up to 4 weeks
|
Tibia axial accelerations were calculated using an IMU (Xsens Technologies BV, Enschede, Netherlands) aligned in the long axis of the participant's tibia attached to the anteromedial aspect of the distal tibia using double-sided adhesive tape.
The mean peak positive acceleration (PPA) was calculated as the mean tibia PPA across all recorded strides for both sides during the exercise above 3g.
|
Up to 4 weeks
|
|
Heart Rate Error
Time Frame: 1 day
|
Heart rate error (HRerr) was calculated as the absolute error between the target heart rate (HRtarget) and the actual heart rate during the steady state exercise.
HRtarget corresponded to 60% heart rate reserve (HRR) of each participant.
HRR was calculated as the difference between the estimated maximal heart rate and the resting heart rate.
Maximal heart rate was estimated using the 220-age formula, and resting heart rate was measured using the heart rate monitor after at least 4 min of seated rest at the beginning of each session.
|
1 day
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-607
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Visual feedback monitoring system (HFFS)
-
Muğla Sıtkı Koçman UniversityCompletedMusculoskeletal PainTurkey
-
Aveiro UniversityCompleted
-
Sunnybrook Health Sciences CentreCompletedArthroplasty | Knee | ReplacementCanada
-
University of British ColumbiaNatural Sciences and Engineering Research Council, Canada; Networks of Centres... and other collaboratorsCompleted
-
University of British ColumbiaNational Council of Science and Technology, Mexico; UBC Peter Wall Institute...Completed
-
Hospices Civils de LyonCompletedSpeech DisordersFrance
-
National Cheng-Kung University HospitalCompletedStroke | Stroke PatientsTaiwan
-
University of Texas at AustinRecruitingStroke | Multiple Sclerosis | Healthy | Muscular Diseases | Movement Disorders | Motor Neuron Disease | Traumatic Brain Injury | Spinal Cord Injuries | Motor DisordersUnited States
-
National Yang Ming UniversityNot yet recruitingStroke Syndrome